Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

PLYMOUTH MEETING, Pa., Oct. 30, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) (the “Company”) today announced the pricing of the previously announced underwritten public offering of an aggregate of 8,000,000 shares of the Company’s common stock, par value $0.00001…